Reportlinker finds all market research
reports published by official sources!
- Home
- Companies
- Companies in P
- PAION AG
- PAION AG - Company Report for Year 2012
PAION AG - Company Report for Year 2012
- This 3-page company report was published in February 2012.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Talk to Sam
+1 917 267 7886
Share
Biopharmaceutical Industry in Germany : Latest Downloads
MorphoSys AG - Company Report for Year 2012
- Company report
- November 2012
- 19 pages
... Of going into even earlier- stage suffes. We also believe that gantenerumab has better properties than solanezumab, in that our antibody was deliberately made to bind and break down amyloid oligomers ...
Company Report: Bioprocessing for Year 2012
- Company report
- October 2012
- 4 pages
... Has yet to agree on definitions for both terms, which can have implications for risk mitigation and raw materials consistency in biopharmaceutical production. The panel will also address questions ...
Company Report: Biopharmaceutical for Year 2012
- Company report
- October 2012
- 32 pages
... Biomarin pharmaceutical inc. (Nasdaq: bmrn) is a multinational biopharmaceutical company that specializes in providing first-to-market therapeutics to patients with rare genetic diseases. Biomarin has ...
Company Report: Biopharmaceutical For Year 20 ...
9 months agoAtmi Inc. - Company Report For Year 2012
9 months agoCompany Report: Biopharmaceutical For Year 20 ...
9 months agoCompany Report: Antibody For Year 2012
12 months agoCompany Report: Biopharmaceutical For Year 20 ...
12 months agoMore Reports:
Biopharmaceutical in Australia (8)
Related Market Segments :
Desmoteplase
Biopharmaceutical Industry in Germany : Latest Reports
Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
Scil Biomedicals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
More Reports:
Biopharmaceutical in China (12)
Related Market Segments :
Desmoteplase
Reportlinker.com © Copyright 2013. All rights reserved.
